Iwatsubo Takeshi
Department of Neuropathology, School of Medicine, University of Tokyo.
Seishin Shinkeigaku Zasshi. 2011;113(6):568-73.
Disease-modifying therapies for Alzheimer's disease are under development based on the outcomes of molecular pathological studies that have progressed over the last 25 years. The current status of basic research on Alzheimer's disease, its translation into clinical applications, and associated problems, will be discussed.
基于过去25年取得进展的分子病理学研究成果，治疗阿尔茨海默病的疾病修饰疗法正在研发中。本文将讨论阿尔茨海默病基础研究的现状、其向临床应用的转化以及相关问题。
